Enrolling by invitationInterventionalNot ApplicableLast updated Aug 12, 2026

Tricuspid Valve Reconstruction Using the Right Atrial Appendage

Overview

ClinicalTrials.gov ID: NCT07761273
Lead Sponsor: Zagazig UniversityOTHER_GOV
Brief Summary: we use part of the cardiac chambre for replacement of destroyed valve on right side of the heart
Study Type: Interventional

Status

Overall Status: Enrolling by invitation
Start Date: Apr 28, 2026Actual
Primary Completion Date: Oct 2026Estimated
Completion Date: Apr 2027Estimated

Study Record Dates

First Submitted: Aug 3, 2026
First Submitted that Met QC Criteria: Aug 11, 2026
First Posted: Aug 12, 2026Actual
Last Update Submitted that Met QC Criteria: Aug 11, 2026
Last Update Posted: Aug 12, 2026Actual
Last Verified: Aug 2026

NCT03775759Completed

Treatment of Tricuspid Valve Regurgitation in Patients Undergoing Left Ventricular Assist Device Implantation Study

NCT02537769Recruiting

Study of the Clinical Impact of Surgical Correction of Tricuspid Insufficiency in Implantable LVAD Patients

NCT03129737Unknown status

PROphylactic triCuspID Annuloplasty in Patients With Dilated Tricuspid Annulus

NCT03600662Recruiting

TriRec - Trileaflet Reconstruction of the Aortic Valve With Autologous Pericardium

NCT02387697Terminated

Treatment of Severe Secondary TRIcuspid Regurgitation in Patients With Advance Heart Failure With CAval Vein Implantation of the Edwards Sapien XT VALve (TRICAVAL)

NCT07516145Recruiting

Robotic Transjugular Transcatheter Tricuspid Valve Replacement